Medication Administration: GLP-1 medications are administered via a daily or weekly injection
Today, more people than ever before are facing the challenges of obesity, diabetes, and arthritisoften all at the same time
Activation of these receptors reduces oxidative stress, lowers inflammatory cytokines, and enhances mitochondrial performance
It also has orforglipron, an oral GLP-1 taken daily that the company plans to file for Food and Drug Administration approval by the end of this year with a goal to begin selling by the middle of 2026
They then regain the weight, often as fat, ending up potentially worse off than before, some developing a condition called sarcopenic obesity, increasing mortality risk